Renowned Medical Journal Publishes Diabliss’s Triumphant Human Clinical Study


Chennai, Tamil Nadu, India, August 16, 2018 – We are pleased to announce that the International Journal of Diabetes Research, a prestigious American Medical Journal, has published Diabliss’s human clinical studies. The study was titled ‘Diabliss’s effect on blood glucose levels in Type-2 Diabetes Mellitus’ and conducted at Sugaen Life Sciences, AP and Annamalai University, TN.

Diabliss is the world’s first diabetic-friendly herbal cane sugar, which is a safe alternative to chemically based artificial sweeteners. It isn’t a medication, but a pure diabetic-friendly glycemic supplementation with low index that can be used in homemade ice creams and sweets. Diabliss is completely safe due to the absence of chemicals (as indicated by independent animal and human clinical trials). The Glycemic Index (GI) of normal sugar is 65 whereas Diabliss sugar is 46.7 indicating Diabliss’s low glycemic index when compared to normal sugar.

The purpose of this clinical study was to evaluate the effect of Diabliss sugar supplementation on blood glucose levels in patients with Type-2 Diabetes Mellitus. Sixteen Type-2 Diabetes Mellitus patients aged between 18 to 55 years who are moderately active, non- smokers, non-alcoholics were considered from India to study efficacy of Diabliss sugar in effective management of Diabetes Mellitus.

Measured quantity of Diabliss sugar was consumed by these subjects three times per day (approx. 7.5 grams each time, total 22.5 grams per day). They maintained their regular diet and activity throughout the study. Blood samples of all the subjects were taken to estimate the fasting and post-prandial blood glucose at baseline 30 days and 60 days.

The results spoke volumes on the efficacy of Diabliss in reduction of blood sugar levels.  The blood glucose levels did not elevate in all the subjects after supplementation of Diabliss sugar during the study period. Rather the post-prandial blood glucose level decreased by 10%!

Mr. VR. Ramanathan, MD & CEO at Diabliss Consumer Products Pvt. Ltd. said jubilantly, “It is an honour that our human clinical trial has been accepted by a reputed American publication like the International Journal of Diabetes Research. Being recognised by such independent bodies gives us added credibility and builds consumer trust on our trials.”


About Diabliss

Diabliss Consumer Products Pvt. Ltd. is an Indian Herbal Company providing science-based functional foods, additives & nutraceuticals globally for diabetics, pre-diabetics and wellness conscious consumers. Commercialising the first of its kind herbal cane sugar under the brand name Diabliss, it has followed pharma-like product testing and development to ensure product efficacy. Diabliss follows ISO 22000-based manufacturing processes and systems, marketing these functional foods in India and overseas.


For Diabliss:

Siva Vallabhaneni

Co-Founder & COO


Phone: +91-44-2254-1392